The results suggest that these OPs can potentially increase breast cancer risk through various mechanisms including increased oxidative stress, disruption of adhesion molecules, acetylcholinesterase inhibition, endocrine disruption, and induction of genomic instability. The gene discussed is ACHE; the disease is breast cancer.